SHBG (sex hormone-binding globulin) modulates the bioavailability of testosterone and estradiol. A direct causal role in sleep is not firmly established. However, low SHBG levels are associated with metabolic conditions such as insulin resistance and visceral obesity, which can impair sleep quality and duration. Additionally, obstructive sleep apnea and circadian disruptions have been linked to altered sex hormone profiles, with SHBG acting as a potential mediator. The evidence is largely associative and mechanistic, lacking robust interventional trials. Therefore, interpreting SHBG variants from consumer DNA tests for sleep outcomes is speculative. A comprehensive assessment including lifestyle, sleep hygiene, and other biomarkers is necessary before drawing conclusions.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-93487d1a96e298593d87d6b6